Otitis media with effusion in under 12s: surgery
In development [GID-NG10193] Expected publication date: TBC
Search results
590 results
-
-
Neonatal infection: antibiotics for prevention and treatment
In development [GID-NG10111] Expected publication date: 13 April 2021
-
Type 1 diabetes in adults: diagnosis and management (update)
In development [GID-NG10159] Expected publication date: 21 July 2021
-
Postnatal care
In development [GID-NG10070] Expected publication date: 13 April 2021
-
Weight Management
In development [GID-NG10182] Expected publication date: 22 June 2023
-
Maternal and child nutrition
In development [GID-NG10191] Expected publication date: 22 November 2023
-
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)
In development [GID-MT526] Expected publication date: TBC
-
Peezy Midstream for urine collection (MT446)
In development [GID-MT538] Expected publication date: TBC
-
The MAGEC system for spinal lengthening in children with scoliosis
In development [GID-MT544] Expected publication date: 15 September 2020
-
GID-MT551 Prontosan for acute and chronic wounds
In development [GID-MT551] Expected publication date: 05 October 2021
-
GID-MT564 GreenLight XPS for treating benign prostatic hyperplasia
In development [GID-MT564] Expected publication date: TBC
-
GID-MT563 NPi-200 for pupillary light reflex in critical care patients
In development [GID-MT563] Expected publication date: TBC
-
GID-MT557 Novii Wireless Patch System for maternal and fetal monitoring (MT509)
In development [GID-MT557] Expected publication date: 22 March 2022
-
GID-MT554 KardiaMobile for the ambulatory detection of atrial fibrillation
In development [GID-MT554] Expected publication date: 06 January 2022
-
MT582 AnaConDa-S for sedation with volatile anaesthetics in intensive care
In development [GID-MT556] Expected publication date: 23 February 2022
-
GID-MT562 FibroScan for assessing liver fibrosis and cirrhosis in primary care
In development [GID-MT562] Expected publication date: TBC
-
GID-MT561 ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections
In development [GID-MT561] Expected publication date: 02 February 2022
-
MT476 UroShield for preventing catheter-associated urinary tract infections
In development [GID-MT560] Expected publication date: 15 March 2022
-
MT507 Plus Sutures for preventing surgical site infection
In development [GID-MT558] Expected publication date: 09 November 2021
-
DHT001 (DHT pilot) myCOPD for self-management of chronic obstructive pulmonary disease (COPD)
In development [GID-MT531] Expected publication date: 29 March 2022
-
GID-MT553 Synergo for non-muscle-invasive bladder cancer
In development [GID-MT553] Expected publication date: 30 November 2021
-
MT539 3C Patch System for treating diabetic foot ulcers
In development [GID-MT559] Expected publication date: 19 January 2022
-
MT461 Endo-SPONGE for treating low rectal anastomotic leakage
In development [GID-MT539] Expected publication date: TBC
-
MT443 Sleepio for adults with difficulty sleeping
In development [GID-MT552] Expected publication date: 07 January 2022
-
Skin abscess: antimicrobial prescribing
In development [GID-NG10163] Expected publication date: TBC
-
Conjunctivitis: antimicrobial prescribing
In development [GID-NG10166] Expected publication date: TBC
-
Stye: antimicrobial prescribing
In development [GID-NG10167] Expected publication date: TBC
-
Blepharitis: antimicrobial prescribing
In development [GID-NG10168] Expected publication date: TBC
-
Clostridioides difficile infection: antimicrobial prescribing
In development [GID-NG10144] Expected publication date: 23 July 2021
-
SACT
In development [GID-NG10184] Expected publication date: TBC
-
Pembrolizumab with trastuzumab and chemotherapy for untreated HER2-positive advanced gastric or gastro-oesophageal junction cancer [ID3742]
In development [GID-TA10615] Expected publication date: TBC
-
Relatlimab with nivolumab for treating advanced malignant melanoma after immunotherapy in people over 12 [ID1612]
In development [GID-TA10484] Expected publication date: TBC
-
Olaparib for treating BRCA 1 or 2 mutated metastatic breast cancer after prior chemotherapy [ID1382]
In development [GID-TA10342] Expected publication date: TBC
-
Third molars (impacted) - prophylactic removal [ID898]
In development [GID-TAG525] Expected publication date: TBC
-
Cediranib with olaparib for treating recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer after 3 therapies [ID1639]
In development [GID-TA10607] Expected publication date: TBC
-
Ixazomib citrate for maintenance treatment of untreated multiple myeloma in people who cannot have autologous stem cell transplant [ID2706]
In development [GID-TA10589] Expected publication date: TBC
-
MTX110 for untreated diffuse intrinsic pontine glioma [ID2695]
In development [GID-TA10573] Expected publication date: TBC
-
Nivolumab-relatlimab for untreated advanced or metastatic melanoma [ID1688]
In development [GID-TA10581] Expected publication date: TBC
-
Pembrolizumab with chemotherapy and surgery for treating resectable gastric or gastro-oesophageal junction cancer [ID2696]
In development [GID-TA10583] Expected publication date: TBC
-
Durvalumab with tremelimumab for untreated unresectable hepatocellular carcinoma [ID2725]
In development [GID-TA10571] Expected publication date: 25 August 2021
-
Belantamab mafodotin for treating relapsed or refractory multiple myeloma after 3 therapies [ID2701]
In development [GID-TA10568] Expected publication date: TBC
-
Durvalumab with chemotherapy for untreated advanced non-small-cell lung cancer with no EGFR or ALK mutations [ID3751]
In development [GID-TA10616] Expected publication date: TBC
-
Durvalumab for treating recurrent or metastatic squamous cell head and neck cancer [ID3752]
In development [GID-TA10617] Expected publication date: TBC
-
Inebilizumab for treating neuromyelitis optica spectrum disorders [ID1529]
In development [GID-TA10522] Expected publication date: TBC
-
Elotuzumab for multiple myeloma [ID966]
In development [GID-TA10134] Expected publication date: TBC
-
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]
In development [GID-TA10429] Expected publication date: TBC
-
Vocimagene amiretrorepvec with extended-release 5-fluorocytosine for treating recurrent high-grade glioma [ID1425]
In development [GID-TA10542] Expected publication date: TBC
-
Entinostat for treating hormone receptor-positive breast cancer after hormonal therapy ID1260
In development [GID-TA10309] Expected publication date: TBC
-
Ibrutinib for untreated mantle cell lymphoma (ID1221)
In development [GID-TA10185] Expected publication date: TBC
-
Enzalutamide with androgen deprivation therapy for treating metastatic hormone-sensitive prostate cancer ID1605
In development [GID-TA10488] Expected publication date: TBC